Release date: 2015-01-21
The National Cancer Research Center of Singapore recently reported details of research related to new cancer vaccines jointly developed by the US FDA and the Singapore Health Sciences Agency. Singapore System takes this opportunity to rank among the world's medical research centers and to create a center that integrates biomedical research and development and production.
MicroVAX of the United States announced the start of the project in August 2014 and cooperated with relevant departments in Singapore to conduct clinical research. The researchers systematically treat a variety of diseases including breast cancer, pancreatic cancer, colorectal cancer, ovarian cancer, and lung cancer by targeting a variety of cancer universal markers. Its essence is still to treat cancer by activating the body's immune system to enhance its ability to recognize tumor cells. This is also the first clinical project approved by the US FDA and the Singapore Health Sciences Board.
Although this treatment is not so unique in the recent wave of cancer immunotherapy, it reflects the decision of Singapore authorities and industry to take this opportunity to make a difference in today's biopharmaceutical industry. In fact, in the past five years, Singapore has cooperated extensively with many world biomedical giants including Novartis, Abbott and Amgen. At the same time, Singapore has also vigorously developed the pharmaceutical processing industry in recent years.
However, Singapore wants to stand out in the Asian pharmaceutical industry and needs to face challenges. In addition to the traditional market in Japan, Taiwan, South Korea and other places have become one of the hot spots for attracting international pharmaceutical companies because of their short drug approval cycle and sound mechanisms.
This also provides a torture for the Chinese biomedical industry: Today, after China has been a "world processing factory" for more than 30 years, when biotechnology research and development is in full swing, we will continue to play in this huge market. The role of the processing plant is still transformed into a competitor and the world's major pharmaceutical giants are determined to be male and female? This is worth pondering in every biomedical industry.
Source: Bio Valley
Gantry Type Video Measuring Instrument
Gantry Type Video Measuring Instrument,Large Image Measuring Instrument,Large Video Measuring Instrument,Video Inspection System
Zhejiang dexun instrument technology co., ltd , https://www.dexunmeasuring.com